PHOTO
Dubai, UAE: Culligan Middle East has earned safety approval from an independent research specialist for the sanitiser developed in the UAE when the company created a new product line in response to the Covid-19 pandemic.
The surface and skin contact sanitiser was adapted through a laboratory process in Dubai from one of Culligan’s range of water treatment products used in the supply of water to industry, hospitals, hotels and homes across the region.
It has a base of hypochlorous acid, a substance the body’s white blood cells produce naturally to combat infection, and Culligan commissioned a report on the product by UK-based Cutest Systems, a leading research organisation specialising in dermatology and ophthalmology.
The report concluded that the Culligan sanitiser qualified as being “highly effective for disinfection” and was “particularly suitable for environmental disinfection applications, such as reducing environmental transmission of viruses between people.”
Culligan Safe Guard 45 H 25 has also been tested and passed by Dubai Central Laboratory and certified both by the Emirates Authority For Standardization & Metrology and Dubai Municipality.
“As a responsible company, our priority is always ensure that our products are safe and effective,” said Culligan Middle East technical director, Rodger Macfarlane. “The safety report is testimony to the dedication of our laboratory team, and the hard work of our production team, to develop the sanitiser from an existing water treatment product in the space of two weeks.”
Ends
For further press information please contact:
Tony Lewis / Narayan Marar
Total Communications
Email: tony@totalcompr.ae / narayan@totalcompr.ae
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
